Cited by 20RNA Interference and Gene DeliveryRNA and protein synthesis mechanismsRNA Research and Splicing

Evaluation of synthetic mRNA with selected UTR sequences and alternative poly(A) tail, in vitro and in vivo

Open access
Medjmedj, Ayoub, Genon, Hugo, Hezili, Dounia, Loth, Albert Ngalle, Clemençon, Rudy, Guimpied, Cyril, Mollet, Lucile, Bigot, Anne +4 more·2025·Molecular Therapy Nucleic Acids

Abstract

Messenger RNA (mRNA) has emerged as an attractive new technology of drugs. The efficacy of mRNA technology depends on both the efficiency of mRNA delivery and translation. Untranslated regions (UTRs) and the poly(A) tail play a crucial role in regulating mRNA intracellular kinetics. Intending to improve the therapeutic potential of synthetic mRNA, we evaluated various UTRs and tail designs, using Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine sequences as a reference. First, we screened six 5′ UTRs (cap-dependent/-independent), evaluated nine 5′ UTR-3′ UTR combinations, and a novel heterologous A/G tail in cell models, and in vivo using luciferase as a reporter gene. Then, to decipher the translation mechanism of selected UTRs, we correlated mRNA expression with ribosome load, mRNA half-life, mRNA immunogenicity, and UTR structures. Our results showed that the heterologous tail we introduced is as potent as the Pfizer-BioNTech tail and confirmed the high potency of the human α-globin 5′ UTR. They also revealed the potential of the VP6 and SOD 3′ UTRs. We validated our results using mRNA encoding the SARS-CoV-2 spike protein formulated as lipid nanoparticles (LNPs) for mouse immunization. Overall, the selected 3′ UTRs and heterologous A/G tail have great potential as new elements for therapeutic mRNA design.

Verified 2026-11-05 · 1 reference not checked yet

AI snapshot

Written from the paper’s full text.

TL;DR

This study systematically evaluated synthetic mRNA designs, including a novel heterologous A/G poly(A) tail and various 5′/3′ UTR combinations, using reporter and SARS-CoV-2 spike mRNAs in cell models and mice. The A/G tail was as potent as the Pfizer-BioNTech A30L70 tail and more stable in bacteria, while VP6 and SOD 3′ UTRs showed potential as alternatives to AES-mtRNR1.

Key findings

  • The novel A/G tail was highly stable in *E. coli* after 10 passages: 100% of clones retained tail integrity, versus 90% for A30L70 and 10% for A120. In HeLa cells, A/G mRNA produced 25% less total protein than A30L70 mRNA, but in mice it produced only 10% less total protein, indicating comparable potency.
  • Cap-independent IRES 5′ UTRs (VCIP, CrPV, EMCV) translated at less than 20% of the human α-globin (hAg) 5′ UTR level across HeLa, C2C12, and DC2.4 cells. hAg, UTR3, and UTR4 were selected as the top cap-dependent 5′ UTRs.
  • Among 5′ UTR–3′ UTR combinations, hAg-VP6 and hAg-SOD produced significantly more protein than the benchmark hAg-AES in C2C12 cells; UTR4-SOD produced less than 50% of benchmark protein in AB1079 human myoblasts. In polysome profiling, UTR3-SOD and UTR4-SOD associated with polysomes at less than 25%.
  • In vivo, UTR3-AES produced 10-fold less protein than hAg-AES with Fluc mRNA. In SARS-CoV-2 spike mRNA vaccination, VP6 and SOD 3′ UTRs produced more spike protein than AES in HeLa and AB1079 cells, improving protein yields by 40% compared to benchmark in human muscle cells, but mouse IgG and neutralizing antibody responses were comparable across groups.

Methods

  • The study compared poly(A) tail designs (A120, A30L70, and a novel A/G tail), seven 5′ UTRs, and nine 5′ UTR–3′ UTR combinations using NanoLuc, firefly luciferase, or SARS-CoV-2 spike reporter mRNAs.
  • Experiments included bacterial passage stability assays, synchrotron radiation circular dichroism (SRCD), transfection into HeLa, C2C12, DC2.4, AB1079, and monocyte-derived dendritic cells, RT-qPCR, FISH-Flow, polysome profiling, luciferase assays, and spike ELISA.
  • In vivo work used BALB/c mice with LNP-formulated mRNA for intramuscular luciferase expression (1 μg mRNA; n = 3–7 per group) and spike immunization (5 μg mRNA; n = 5 per group, two doses), with bioluminescence imaging, anti-spike IgG ELISA, and neutralizing antibody assays; statistical analysis used nested one-way ANOVA or Kruskal-Wallis tests.

Limitations

  • The paper states that the A/G tail can be further improved by optimizing the percentage of G residues and overall tail length, and that future studies will evaluate poly(A)-binding protein (PABP) binding.
  • The paper notes that predicting optimal 5′/3′ UTR combinations is challenging due to tissue- and cell-type dependencies and RNA folding that can be affected by the coding sequence.
  • Evident from the text: in vivo experiments were limited (one experiment with small group sizes; UTR in vivo n = 3–7, immunization n = 5), and no statistically significant differences in IgG or neutralizing antibodies were observed among the three 3′ UTRs after boost, nor for the A/G tail versus A30L70 IgG comparison.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.omtn.2025.102648

Cites

57 of 58 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

23 of 36 cited sources checked · 13 supported · 1 flagged · accuracy not yet measured

  • Premisecitation

    UTRs and the poly(A) tail play a crucial role in regulating mRNA intracellular kinetics.

    “Untranslated regions (UTRs) and the poly(A) tail play a crucial role in regulating mRNA intracellular kinetics.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [4] Kang, 2023, Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics, Adv. Drug Deliv. Rev. source
  • Premisecitation

    The presence of the poly(A) tail on the plasmid template for mRNA production is not stable and prone to shortening in bacteria during plasmid DNA amplification.

    “However, the presence of the poly(A) tail on the plasmid template for mRNA production is not stable and prone to shortening in bacteria during plasmid DNA amplification.17”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [17] Grier, 2016, pEVL: A Linear Plasmid for Generating mRNA IVT Templates With Extended Encoded Poly(A) Sequences, Mol. Ther. Nucleic Acids source

      The Results section (‘Homopolymeric poly(A) tracts 175 bp or longer are extremely unstable in circular plasmids’; page not provided) reports shortening after bacterial transformation of circular plasmids carrying long poly(A) tracts. The claim omits important limits: 70-bp tracts remained stable, and another Results section reports that poly(A) tracts in the linear pEVL plasmid were highly stable during extended propagation, except that the ~500-bp tract tended to shorten. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Premisecitation

    The translation initiation efficiency of mRNA is affected by the sequence and structure of the 5′ UTR region.

    “The translation initiation efficiency of mRNA is affected by the sequence and structure of the 5′ UTR region.5”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [5] Hinnebusch, 2016, Translational control by 5′-untranslated regions of eukaryotic mRNAs, Science source
  • Premisecitation

    The synthetic 5′ UTR UTR4 allows strong expression of mRNA in cells and Zebrafish.

    “the synthetic 5′ UTR UTR4 allowing strong expression of mRNA in cells and Zebrafish27”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [27] Linares-Fernández, 2021, Combining an optimized mRNA template with a double purification process allows strong expression of in vitro transcribed mRNA, Mol. Ther. Nucleic Acids source
  • Premisecitation

    Incorporation of non-A nucleotides, particularly guanosine, can interfere with the deadenylation process, thereby enhancing mRNA stability.

    “Previous studies have shown that the incorporation of non-A nucleotides, particularly guanosine, can interfere with the deadenylation process, thereby enhancing mRNA stability.41”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [41] Lee, 2024, Deadenylation kinetics of mixed poly(A) tails at single-nucleotide resolution, Nat. Struct. Mol. Biol. source
  • Classified as probably not a substantial claim. 16
  • May combine two claims. 25
  • The quote only partly states this claim. 1
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The IRES from Cricket paralysis virus (CrPV) is able to directly recruit the 60S subunit.

    “the IRES from Cricket paralysis virus (CrPV) that is able to directly recruit the 60S subunit.29”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [29] Gross, 2017, The IRES5′UTR of the dicistrovirus cricket paralysis virus is a type III IRES containing an essential pseudoknot structure, Nucleic Acids Res. source

      The Introduction (page unavailable) says type III IRESs bind directly to the 40S ribosomal subunit, and the paper identifies the CrPV 5′UTR IRES as type III. It does not say that this IRES directly recruits the 60S subunit; the specified subunit is contrary to the claim. (LLM, conf=0.88)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    Guanylation stabilizes mRNA by reducing deadenylation, and cellular mRNAs with non-A tails are highly translated.

    “Furthermore, guanylation has been reported to stabilize mRNA by reducing deadenylation20,22 and that cellular mRNAs with non-A tails are highly translated.22”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites [20] Lim, 2018, Mixed tailing by TENT4A and TENT4B shields mRNA from rapid deadenylation, Science source
    • cites [22] Liu, 2021, Enhancement of synthetic mRNA translation efficiency through engineered poly(A) tails, bioRxiv source
  • May combine two claims.

    Premisecitation

    The interactions between 5′ and 3′ UTR are crucial and can modulate the mRNA translation efficiency.

    “The interactions between 5′ and 3′ UTR are crucial and can modulate the mRNA translation efficiency.44”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [44] Kirshina, 2023, Effects of Combinations of Untranslated-Region Sequences on Translation of mRNA, Biomolecules source

      The Discussion reports that combinations of 5′ and 3′ UTRs affected protein expression, primarily through translational efficiency. But the Conclusions describe their influence on each other as indirect, and the Introduction says they do not interact directly during translation. The claim overstates the evidence by calling their interactions crucial without that qualification. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim.

    Premisecitation

    The human Hsp70 5′ UTR is reported to be a general enhancer of mRNA translation.

    “the human Hsp70 5′ UTR reported to be a general enhancer of mRNA translation26”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [26] Vivinus, 2001, An element within the 5′ untranslated region of human Hsp70 mRNA which acts as a general enhancer of mRNA translation, Eur. J. Biochem. source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The CleanCap AG trinucleotide cap analog is used in the Pfizer-BioNTech vaccine.

    “we also evaluated the translatability of three mRNAs harboring the CleanCap AG trinucleotide cap analog used in the Pfizer-BioNTech vaccine.37,38”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [37] Warminski, 2023, Chemical Modifications of mRNA Ends for Therapeutic Applications, Acc. Chem. Res. source

      The “How to Cap RNA” section says trinucleotide cap analogs are sold as CleanCap reagents and that a modified trinucleotide cap was used to produce the Comirnaty vaccine. It does not identify that vaccine cap as CleanCap AG, so the specific product attribution is unsupported. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [38] Sahin, 2020, COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses, Nature source

      The Manufacturing of RNA section says the Pfizer–BioNTech vaccine candidate BNT162b1 used a TriLink trinucleotide cap 1 analogue with the stated chemical structure. The Article section says a different candidate, BNT162b2, was selected to advance to phase II/III. This paper therefore supports use of a trinucleotide cap in BNT162b1, but does not establish that the marketed Pfizer–BioNTech vaccine uses CleanCap AG; it also does not name the cap as CleanCap AG. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Vaccination is the only approved application of synthetic mRNA.

    “Vaccination is the only approved application of synthetic mRNA.2,4”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [2] Barbier, 2022, The clinical progress of mRNA vaccines and immunotherapies, Nat. Biotechnol. source
    • cites [4] Kang, 2023, Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics, Adv. Drug Deliv. Rev. source
  • May combine two claims.

    Premisecitation

    The Pfizer-BioNTech mRNA vaccine contains the 5′ UTR of human α-globin and the 3′ UTR AES-mtRNR1 combination.

    “the Pfizer-BioNTech mRNA vaccine contains the 5′ UTR of human α-globin, which was identified as one of the top 20% 5′ UTRs in massive screening studies,10,11,13 and the 3′ UTR AES-mtRNR1 combination of two genes, AES (Amino Enhancer of Split) and mtRNR1 (12S mitochondrial RNA).12”
    Quote in the paperNot a substantial claim3 of 3 sources checked
    • cites [10] Castillo-Hair, 2024, Optimizing 5’UTRs for mRNA-delivered gene editing using deep learning, Nat. Commun. source

      The Introduction says many mRNA therapies use alpha- or beta-globin UTRs. The Results section on de novo designed 5′UTRs places the commonly used beta-globin UTR—not alpha-globin—in the top ~20% of short endogenous UTRs. This paper therefore does not establish the cited ranking for alpha-globin or identify it as the Pfizer-BioNTech vaccine’s 5′UTR; the sentence cites a different source for the 3′UTR combination. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [11] Sample, 2019, Human 5′ UTR design and variant effect prediction from a massively parallel translation assay, Nat. Biotechnol. source

      The Results (MPRA design and validation) and Online Methods (Design and Synthesis of varying Lengths 5′ UTR Sequences) describe large-scale screening of human 5′ UTRs, but the passages found do not identify α-globin’s UTR as being in the top 20% or discuss the Pfizer-BioNTech vaccine. Searches for globin, HBA1/HBA2, the top-20% ranking, and the vaccine found no passage establishing those points. The AES-mtRNR1 portion of the citing sentence is attached to a different citation. (LLM, conf=0.75)

      Experimental — accuracy not yet measured
    • cites [13] Xia, 2021, Detailed Dissection and Critical Evaluation of the Pfizer/BioNTech and Moderna mRNA Vaccines, Vaccines source
  • May combine two claims.

    Premisecitation

    The Hsp70 5′ UTR has an enhancer element and can promote translation via both cap-dependent and cap-independent mechanisms.

    “The higher expression of Hsp70 5′ UTR-mRNA in DC 2.4 may be attributed to an enhancer element in its sequence and to its capability to promote translation via both cap-dependent and cap-independent mechanisms.26,31”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [26] Vivinus, 2001, An element within the 5′ untranslated region of human Hsp70 mRNA which acts as a general enhancer of mRNA translation, Eur. J. Biochem. source

      The Abstract identifies a human Hsp70 5′ UTR element that enhances translation, and the Discussion says it improves translation during cap-dependent protein synthesis. The section “The Hsp70 5′ UTR does not behave as an IRES” reports no IRES activity; the Discussion leaves translation when cap-dependent synthesis is downregulated as an open question. This paper therefore does not support the cap-independent part of the claim. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [31] Rubtsova, 2003, Distinctive Properties of the 5′-Untranslated Region of Human Hsp70 mRNA, J. Biol. Chem. source

      The Discussion reports that the Hsp70 5′ UTR contains a strong IRES and directs cap-independent translation. It also notes an enhancing effect on reporter translation in monocistronic constructs. The paper does not establish that the UTR promotes translation through a cap-dependent mechanism as well, so the claim about both mechanisms is not fully supported. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    IRES elements are known to function more effectively under stress conditions.

    “as IRES elements are known to function more effectively under stress conditions.30”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [30] Godet, 2019, IRES Trans-Acting Factors, Key Actors of the Stress Response, Int. J. Mol. Sci. source
  • May combine two claims.

    Premisecitation

    The study by Liu et al. did not evaluate stability of templates nor translation efficiency in human primary cells or in vivo.

    “This study did not evaluate stability of templates nor translation efficiency in human primary cells or in vivo.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [22] Liu, 2021, Enhancement of synthetic mRNA translation efficiency through engineered poly(A) tails, bioRxiv source

      The cell-culture and transfection Methods describe translation experiments in HeLa cells, not human primary cells, and the paper does not report an in vivo test of the engineered mRNAs. But the 'Non-A residues promote translation efficiency of IVT mRNA' section uses qPCR to assess whether increased protein production reflects mRNA stability, while the 'non-A residues are associated with high translation efficiency in vivo' section analyzes translation efficiency of endogenous mRNAs in mouse oocytes. The blanket statement that the study did not evaluate template stability or translation efficiency in vivo is therefore too broad. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Findingown data

    All tested mRNAs exhibited similar time-dependent decay and comparable half-life, except hAg-VP6, which seemed slightly more stable than the benchmark especially after 96 h.

    “All tested mRNAs exhibited a similar time-dependent decay and a comparable half-life, except for mRNA hAg-VP6, which seemed to be slightly more stable than the benchmark mRNA, especially after 96 h (Figures 5A and 5B).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In HeLa cells, hAg-AES, hAg-VP6, and UTR4-AES mRNAs showed more pronounced association with polysomes, while UTR3-SOD and UTR4-SOD showed lower association (less than 25%).

    “Notably, hAg-AES, hAg-VP6, and UTR4-AES showed more pronounced association with polysomes, while UTR3-SOD and UTR4-SOD showed lower association (less than 25%) (Figure 5D).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Neutralizing antibody responses were similar across groups, with a marked increase following the booster injection.

    “While there were some variations in IgG production, neutralizing antibody responses were similar across groups, with a marked increase following the booster injection (Figure 7D).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The Hsp70 5′ UTR exhibited lower translation efficiency than α-globin in C2C12 cells, equivalent performance in HeLa cells, and superior translation in DC2.4 cells.

    “Interestingly, the performance of the Hsp70 5′ UTR varied among the three cell lines: it exhibited lower translation efficiency than α-globin in C2C12 cells, equivalent performance in HeLa cells, and superior translation in DC 2.4 cells.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Preheated UTR3-AES Fluc mRNA produced two times more protein than unheated mRNA, whereas UTR3-VP6 Fluc mRNA produced the same amount regardless of preheating.

    “Interestingly, the preheated UTR3-AES Fluc mRNA produced two times more protein than the unheated mRNA, whereas UTR3-VP6 Fluc mRNA produced the same amount of protein regardless of preheating (Figure S3B).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In AB1079 human myoblasts, UTR3-SOD and UTR4-VP6 produced 25% less protein and UTR4-SOD produced less than 50% of the protein compared to the benchmark hAg-AES.

    “The results in AB1079 cells mirrored the pattern obtained in C2C12 cells, except for UTR3-SOD, UTR4-VP6, which produced 25% less protein, and UTR4-SOD mRNA, which produced less than 50% of the protein compared to the benchmark mRNA (Figure 4F).”
    Quote in the paperSubstantial claim
  • The quote only partly states this claim.

    Findingown data

    In BALB/c mice, A/G tail produced only 10% less total protein than A30L70.

    “The AUC analysis revealed that A/G tail produced only 10% less total protein compared to A30L70 (Figure 2E).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In DC2.4 cells, UTR4-SOD mRNA was translated 2-fold less than the benchmark, while other mRNAs showed similar protein expression.

    “Remarkably, in DC 2.4, we found that the UTR4-SOD mRNA pair was translated 2-fold less than the benchmark, while the other mRNAs showed similar protein expression (Figure 4E).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    In E. coli, the A/G tail had 100% clone integrity after 10 passages, compared with 90% for A30L70 and 10% for A120.

    “We found that only 10% of the clones with A120 tail retained the full 120A tract, confirming the reported instability of homopolymeric A tails.17 In contrast, the A30L70 and A/G tails demonstrated high stability, with 90% and 100% of clones keeping the integrity of the poly(A) tail, respectively (Figure 1B).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In HeLa cells, eight of the nine 5′ UTR-3′ UTR combinations tested had similar translation kinetics and total protein production over time; UTR4-SOD produced less protein than the benchmark hAg-AES.

    “As shown in Figures 4B and 4C, eight of the nine combinations tested had similar translation kinetics and total protein production over time in HeLa cells. The UTR4-SOD mRNA was the only mRNA that produced less protein than the benchmark.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In MoDCs, five of the nine mRNAs (hAg-AES, hAg-VP6, hAg-SOD, UTR3-AES, and UTR4-AES) were similarly translated, while mRNA with 3′ UTR VP6 or SOD in combination with UTR3 or UTR4 5′ UTRs resulted in decreased translation.

    “In MoDCs, five of the nine mRNAs tested were similarly translated (hAg-AES, hAg-VP6, hAg-SOD, UTR3-AES, and UTR4-AES), and mRNA with 3′ UTR VP6 or SOD in combination with UTR3 or UTR4 5′ UTRs resulted in decreased mRNA translation (Figure 4G).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The A/G tail showed a tendency of higher IgG production after 2 and 3 weeks compared to the A30L70 tail, although the difference was not statistically significant.

    “Regarding the tails, the A/G tail revealed a tendency of higher IgG production after 2 and 3 weeks compared to the A30L70 tail, although the difference was not statistically significant (Figures 7F and 7G).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    All nine UTR constructs had the same percentage of dsRNA content and induced comparable activation of the interferon pathway in DC2.4 cells.

    “However, all the constructs had the same percentage of dsRNA content (Table S2) and induced comparable activation of the interferon pathway in DC2.4 cells (Figure S2).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    In BALB/c mice, total protein production from the eight UTR combinations reached equivalent levels except for UTR3-AES mRNA, which produced 10-fold less protein than hAg-AES mRNA.

    “Total protein production reached equivalent levels for all mRNAs except for UTR3-AES mRNA, which produced 10-fold less protein than hAg-AES mRNA (Figure 6).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The A30L70 and A/G tails exhibited similar Tm and SRCD profiles.

    “The structural analysis revealed that the A30L70 and A/G tails exhibited a similar Tm and SRCD profiles, suggesting comparable structural properties.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingreasoning

    With nanoluciferase ORF, protein levels from neoUTR3/AES-mtRNR1 were similar to the benchmark, whereas with firefly luciferase ORF, they were 10-fold lower compared to the benchmark in vivo.

    “With nanoluciferase ORF, protein levels were similar to the benchmark, whereas with firefly luciferase ORF, they were 10-fold lower compared to the benchmark in vivo.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Premisecitation

    Poly(A) stretches of 30 and 70 adenosines separated by a 10 nt linker (A30L70 tail) resulted in more stable poly(A) tails on plasmid templates.

    “BioNTech demonstrated that poly(A) stretches of 30 and 70 adenosines separated by a 10 nt linker (A30L70 tail) resulted in more stable poly(A) tails on plasmid templates.18”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [18] EBERLE, 2016

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationown data

    UTR3-AES Fluc mRNA is structured and potentially less accessible to the ribosome.

    “suggesting that UTR3-AES Fluc mRNA is structured and potentially less accessible to the ribosome (Figure S7).”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    The poly(A) tail protects mRNA from degradation and is required to form a closed loop between the 5′ and 3′ ends that stimulates translation.

    “It protects the mRNA from degradation15 and is required to form a closed loop between the 5′ and 3′ ends of the mRNA, a conformation that stimulates translation.16”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [15] Goldstrohm, 2008, Multifunctional deadenylase complexes diversify mRNA control, Nat. Rev. Mol. Cell Biol. source
    • cites [16] Amrani, 2008, Translation factors promote the formation of two states of the closed-loop mRNP, Nature source
  • May combine two claims.

    Study design and conductown data

    The resulting LNPs measured 95-120 nm with a PDI <0.2 and exhibited an encapsulation efficiency of 90%-95%.

    “The resulting LNPs measured 95–120 nm with a PDI <0.2 (Figure S10) and exhibited an encapsulation efficiency of 90%–95% (data not shown).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    All animal procedures were approved by the French Ministry of Research.

    “All animal procedures were approved by the French Ministry of Research (#30279 for intramuscular injection of luciferase mRNA, #44268 for immunization with Spike mRNA).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    The higher expression with CleanCap AG is likely due to higher capping efficiency (up to 98%) and lower dsRNA levels.

    “CleanCap AG yielded up to 2-fold more expression compared to ARCA in DC2.4 and MoDCs (Figure S4), likely due to higher capping efficiency (up to 98%) and lower dsRNA levels.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The parameters of the IVT and the choice of downstream purification are crucial for improved translation efficiency.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The LNP composition used was the same as the Pfizer-BioNTech vaccine.

    “LNPs with the same composition as the Pfizer-BioNTech vaccine23 were used to deliver A30L70- or A/G-tailed mRNA encoding firefly luciferase (Fluc) by intramuscular injection”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [23] Sosnick, 2001, Characterization of Tertiary Folding of RNA by Circular Dichroism and Urea, Curr. Protoc. Nucleic Acid Chem. source

      Checked before — its earlier verdict is held back until a new check runs.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    The constructs were verified by restriction enzyme analysis and Sanger sequencing.

    “The constructs were verified by restriction enzyme analysis and Sanger sequencing performed by Eurofins (Ebersberg, Germany).”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisenone given

    The benchmark Comirnaty uses hAg-AES with A30L70 tail.

    “the benchmark Comirnaty (hAg-AES with A30L70 tail)”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    COVID-19 vaccines required intramuscular administration of mRNA-LNP and expression of the mRNA-encoded antigen in antigen-presenting cells such as dendritic cells to induce a protective immune response.

    “COVID-19 vaccines required intramuscular administration of mRNA-LNP and expression of the mRNA-encoded antigen in antigen-presenting cells such as dendritic cells (DC) to induce a protective immune response.34”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [34] Kuhn, 2011, Determinants of intracellular RNA pharmacokinetics: Implications for RNA-based immunotherapeutics, RNA Biol. source

      Checked before — its earlier verdict is held back until a new check runs.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    All cell lines were confirmed mycoplasma-free using the MycoAlert Mycoplasma Detection Kit.

    “All cell lines were confirmed mycoplasma-free using the MycoAlert Mycoplasma Detection Kit (Lonza).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Spectral magnitudes were calibrated using a solution of camphorsulfonic acid (CSA) at a known concentration.

    “Spectral magnitudes were calibrated using a solution of camphorsulfonic acid (CSA) at a known concentration.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The integrity and quality of the purified mRNA was verified by capillary electrophoresis using an Agilent 2100 Bioanalyzer.

    “The integrity and quality of the purified mRNA was verified by capillary electrophoresis using an Agilent 2100 Bioanalyzer.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    mRNA tails containing C and G residues were more efficiently translated than mRNA with pure A tails in HeLa cells.

    “A recent study by Liu et al. reported that mRNA tails containing C ang G residues were more efficiently translated than mRNA with pure A tails in HeLa cells.22”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [22] Liu, 2021, Enhancement of synthetic mRNA translation efficiency through engineered poly(A) tails, bioRxiv source

      Checked before — its earlier verdict is held back until a new check runs.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Integrity of poly(A) tails was verified by Sanger sequencing.

    “Integrity of tails was verified by Sanger sequencing performed by Eurofins (Ebersberg, Germany).”
    Quote in the paperNot a substantial claim
41 of 41
  • The paper relies on this without support.

    Predicting the optimal combination of 5′ and 3′ UTR remains challenging due to tissue and cell-type dependencies, and RNA folding of UTRs, which can be affected by the coding sequence.

    “However, predicting the optimal combination of 5′ and 3′ UTR remains challenging due to tissue and cell-type dependencies, and RNA folding of UTRs, which can be affected by the coding sequence.”
  • The paper relies on this without support.

    The efficacy of mRNA technology depends on both the efficiency of mRNA delivery and translation.

    “The efficacy of mRNA technology depends on both the efficiency of mRNA delivery and translation.”
  • The paper relies on this without support.

    Translation efficiency and mRNA stability of synthetic mRNA are directly linked to its design elements (Cap, UTR, codon usage, and poly(A) tail), IVT parameters, and downstream purification.

    “Translation efficiency and mRNA stability of synthetic mRNA are directly linked to its design elements (Cap, UTR, codon usage, and poly(A) tail), IVT parameters, and downstream purification.”
  • The paper relies on this without support.

    Another key element in mRNA translation efficiency and stability is the 5′ and 3′ UTRs.

    “Another key element in mRNA translation efficiency and stability is the 5′ and 3′ UTRs.”
  • The paper relies on this without support.

    The parameters of the IVT and the choice of downstream purification are crucial for improved translation efficiency.

    “In addition to optimizing synthetic mRNA sequences, the parameters of the IVT and the choice of downstream purification are crucial for improved translation efficiency.”
5 of 5

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Inclusion of specific untranslated regions is a promising strategy to enhance stability and efficacy of mRNA therapeutics.

    “Recent studies demonstrate that, in addition to the incorporation of modified nucleosides, the inclusion of specific untranslated regions represents a highly promising strategy to enhance the stability and efficacy of mRNA therapeutics [12][13][14][15][16].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Figure 1B is cited for two different measurements

    Minor

    The results cite Figure 1B for bacterial tail stability, but the figure caption assigns tail stability to panel A and melting temperatures to panel B.

  • The first mouse immunization is assigned two different days

    Minor

    The results place the first injection on day 0, while the methods place it on day 1.

  • The number of 5′ UTRs screened changes from six to seven

    Minor

    The abstract says six 5′ UTRs were screened, whereas the introduction says seven were compared.

  • The poorly performing Fluc combination is named inconsistently

    Minor

    The passage identifies UTR3-AES as the combination with poor Fluc expression, then calls it UTR3-SOD when introducing the investigation of that result.

4 of 4

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Medjmedj, A., Genon, H., Hezili, D., Loth, A. N., Clemençon, R., Guimpied, C., Mollet, L., Bigot, A., Wien, F., Hamacek, J., Chapat, C., & Perche, F.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • Inserm (FR)
  • Synchrotron SOLEIL (FR)
Corresponding author
Perche, Federico
Venue
Molecular Therapy Nucleic Acids
Publisher
Elsevier BV
Published
2025-09
Volume
36
Issue
3
Pages
102648
ISSN
2162-2531 (ISSN-L)
OpenAlex
W4412764102
Cited by
19
References
57
Citations by year
2026: 18 · 2025: 1
FWCI
5.25
Type
journal article
Language
en
Open access
Locations
  • Molecular Therapy — Nucleic Acids (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Agence Nationale de la Recherche (ANR-21-CE18-0037, 20231392)
  • Conseil National de la Recherche Scientifique
  • National Centre for Scientific Research
  • National League Against Cancer
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Keywords
synthetic mRNA, mRNA 3' UTR, poly(A) tail, 5' untranslated region, mRNA half-life, luciferase reporter, SARS-CoV-2 spike protein, lipid nanoparticle mRNA vaccine, mRNA vaccine design

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-11-05.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-11-05.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review